Simple and reliable high-performance liquid chromatography fluorimetric procedure for the determination of amphetamine-derived designer drugs

被引:16
作者
Mancinelli, R [1 ]
Gentili, S [1 ]
Guiducci, MS [1 ]
Macchia, T [1 ]
机构
[1] Ist Super Sanita, Dept Clin Biochem, Drug Abuse Sect, I-00161 Rome, Italy
来源
JOURNAL OF CHROMATOGRAPHY B | 1999年 / 735卷 / 02期
关键词
amphetamines; methylenedioxylated amphetamines;
D O I
10.1016/S0378-4347(99)00440-5
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The paper describes a HPLC-fluorimetric procedure for the determination of methylenedioxyamphetamine, methylenadioxymethamphetamine, methylenedioxyethamphetamine and N-methyl-1-(1,3-benzodioxol-5-yl)-2-butamine in urine, serum, saliva and street samples, that features interesting advantages over other procedures previously described. The method requires a very small sample volume (100 mu l) and no extraction, lacks matrix effect, and is not time consuming. Linearity was in the range 50-1000 ng/ml regardless of matrix. Sensitivity and detection Limit were 50 ng/ml and 10 ng/ml, respectively, but they may reach 10 ng/ml and 2 ng/ml if a slight modification is introduced in the procedure. Intra- and inter-day precision were always within 5% and 8%, respectively. Recovery was satisfactory for all matrices. The described procedure could be successfully used for clinical, epidemiological and forensic applications. (C) 1999 Elsevier Science BN. All rights reserved.
引用
收藏
页码:243 / 253
页数:11
相关论文
共 25 条
  • [1] Baselt R.C., 1989, DISPOSITION TOXIC DR
  • [2] Quantitation of N-ethyl-3,4-methylenedioxyamphetamine and its major metabolites in human plasma by high-performance liquid chromatography and fluorescence detection
    Brunnenberg, M
    Lindenblatt, H
    Gouzoulis-Mayfrank, E
    Kovar, KA
    [J]. JOURNAL OF CHROMATOGRAPHY B, 1998, 719 (1-2): : 79 - 85
  • [3] GARRETT ER, 1991, ACTA PHARM NORDICA, V3, P9
  • [4] GRIFFITHS P, 1997, INSIGHTS EMCDDA SERI
  • [5] Simple extractive derivatization of methamphetamine and its metabolites in biological materials with Extrelut(R) columns for their GC-MS determination
    Hara, K
    Kashimura, S
    Hieda, Y
    Kageura, M
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1997, 21 (01) : 54 - 58
  • [6] Analysis of 3,4-methylenedioxymethamphetamine (MDMA) and its metabolites in plasma and urine by HPLC-DAD and GC-MS
    Helmlin, HJ
    Bracher, K
    Bourquin, D
    Vonlanthen, D
    Brenneisen, R
    Styk, J
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1996, 20 (06) : 432 - 440
  • [7] KAJITANI A, 1989, JPN J EXP MED, V59, P197
  • [8] Testing for drugs of abuse in saliva and sweat
    Kidwell, DA
    Holland, JC
    Athanaselis, S
    [J]. JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 1998, 713 (01): : 111 - 135
  • [9] Identification of N-methyl-1-(3,4-methylenedioxyphenyl)-2-butanamine (MBDB) in urine from drug users
    Kronstrand, R
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1996, 20 (06) : 512 - 516
  • [10] APPLICATION OF THE SYVA EMIT AND ABBOTT TDX AMPHETAMINE IMMUNOASSAYS TO THE DETECTION OF 3,4-METHYLENE-DIOXYMETHAMPHETAMINE (MDMA) AND 3,4-METHYLENE-DIOXYETHAMPHETAMINE (MDEA) IN URINE
    KUNSMAN, GW
    MANNO, JE
    COCKERHAM, KR
    MANNO, BR
    [J]. JOURNAL OF ANALYTICAL TOXICOLOGY, 1990, 14 (03) : 149 - 153